This video is normally available to paying customers.
You may unlock this video for FREE. Enter your email address for instant access AND to receive ongoing updates and special discounts related to this topic.
Progressive Supranuclear Palsy (PSP) is a rare and progressive neurological condition. As the name suggests, it involves a gradual decline in function. PSP is characterised by a supranuclear gaze palsy, leading to difficulties with vertical eye movements, both upwards and downwards.
With a prevalence of approximately six in every 100,000 people, PSP is as common as motor neurone disease. The PSP Society estimates that around 10,000 people in the UK are currently affected by this condition. Despite its rarity, PSP is often less well-known compared to motor neurone disease, which has received significant media attention.
PSP manifests through a variety of symptoms, some of which can be subtle. Early signs include:
Distinguishing PSP from Parkinson's disease can be challenging due to overlapping symptoms. The clinical picture typically becomes clearer over time, aiding in diagnosis. Key indicators of PSP include:
Vision problems are a significant feature of PSP. Affected individuals may experience:
Individuals with PSP may struggle with various eye issues, including:
Managing PSP involves adapting to its symptoms and making necessary adjustments. Regular consultations with healthcare professionals and support groups can provide valuable insights and assistance. Despite the challenges, maintaining a positive outlook and seeking appropriate support can significantly improve quality of life.